Samson Rock Capital LLP Tyra Biosciences, Inc. Transaction History
Samson Rock Capital LLP
- $128 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding TYRA
# of Institutions
77Shares Held
32.4MCall Options Held
600Put Options Held
3.7K-
Boxer Capital, LLC San Diego, CA6.45MShares$109 Million5.5% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$79.1 Million2.29% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$74.8 Million79.77% of portfolio
-
Nextech Invest Ag4.06MShares$68.8 Million12.44% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA1.99MShares$33.8 Million3.43% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $712M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...